Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1986-7-25
|
pubmed:abstractText |
Four children with measles meningoencephalitis were treated with thymostimulin, a calf thymic extract. All patients were comatose when therapy was started. In all but one a good and sometimes rapid clinical improvement was observed. In the responsive patients no neurological or EEG sequellae were noted over a follow-up period of 1-4 years. The depression of cell-mediated immunity, present in some patients before treatment, normalised at the end of therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0165-6090
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3726944-Child,
pubmed-meshheading:3726944-Female,
pubmed-meshheading:3726944-Follow-Up Studies,
pubmed-meshheading:3726944-Humans,
pubmed-meshheading:3726944-Immunity, Cellular,
pubmed-meshheading:3726944-Male,
pubmed-meshheading:3726944-Measles,
pubmed-meshheading:3726944-Meningoencephalitis,
pubmed-meshheading:3726944-Thymus Extracts
|
pubmed:year |
1986
|
pubmed:articleTitle |
Thymostimulin therapy in patients with measles meningoencephalitis.
|
pubmed:publicationType |
Journal Article,
Case Reports
|